F‐MWNT‐ANG exhibited enhanced uptake in the glioma brain compared to the non‐targeted conjugate, demonstrating the potential of ANG‐conjugated f‐MWNTs for effective drug delivery to brain malignancies. The gene discussed is ANG; the disease is glioma.